Safety and efficacy of optimized tandem CD19/CD20 CAR-engineered T cells in patients with relapsed/refractory non-Hodgkin lymphoma.

被引：0
|
作者：
Zhang, Yajing [1 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3034
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma
    Tong, Chuan
    Zhang, Yajing
    Liu, Yang
    Ji, Xingyu
    Zhang, Wenying
    Guo, Yelei
    Han, Xiao
    Ti, Dongdong
    Dai, Hanren
    Wang, Chunmeng
    Yang, Qingming
    Liu, Wanli
    Wang, Yao
    Wu, Zhiqiang
    Han, Weidong
    BLOOD, 2020, 136 (14) : 1632 - 1644
  • [2] Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma (vol 136, pg 1632, 2020)
    Tong, C.
    Zhang, Y.
    Liu, Y.
    Wang, Yao
    Wu, Zhiqiang
    Han, Weidong
    BLOOD, 2023, 141 (15) : 1896 - 1896
  • [3] CD19/CD20 bispecific chimeric antigen receptor (CAR) in naive/memory T cells for the treatment of relapsed or refractory non-Hodgkin lymphoma
    Larson, Sarah Marie
    Walthers, Christopher
    Ji, Brenda
    Ghafouri, Sanaz N.
    Naparstek, Jacob
    Trent, Jacqueline
    Harris, Caitlin
    Gandhi, Mobina Khericha
    Schweppe, Thomas
    Auerbach, Martin S.
    Said, Jonathan W.
    Nawaly, Karla
    Mead, Monica Diane
    De Vos, Sven
    Young, Patricia
    Oliai, Caspian
    Schiller, Gary J.
    Timmerman, John
    Ribas, Antoni
    Chen, Yvonne Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Phase 1 trial of CD19/CD20 bispecific chimeric antigen receptor-engineered naive/memory T cells for relapsed or refractory non-Hodgkin lymphoma
    Puliafito, Benjamin R.
    Walthers, Christopher
    Ji, Brenda
    Ghafouri, Sanaz N.
    Naparstek, Jacob
    Trent, Jacqueline
    Chen, Jia M.
    Roshandell, Mobina
    Harris, Caitlin
    Khericha, Mobina
    Schweppe, Thomas
    Berent-Maoz, Beata
    Gosliner, Stanley B.
    Almaktari, Amr
    Ceja, Melanie Ayala
    Allen-Auerbach, Martin S.
    Said, Jonathan
    Nawaly, Karla
    Mead, Monica
    de Vos, Sven
    Young, Patricia A.
    Oliai, Caspian
    Schiller, Gary J.
    Timmerman, John M.
    Ribas, Antoni
    Chen, Yvonne Y.
    Larson, Sarah M.
    CANCER RESEARCH, 2023, 83 (08)
  • [5] Fresh Versus Cryopreserved/Thawed Bispecific Anti-CD19/CD20 CAR-T Cells for Relapsed, Refractory Non-Hodgkin Lymphoma
    Shah, Nirav N.
    Zhu, Fenlu
    Schneider, Dina
    Krueger, Winfried
    Worden, Andrew
    Longo, Walter L.
    Hamadani, Mehdi
    Fenske, Timothy S.
    Dropulic, Boro
    Orentas, Rimas J.
    Hari, Parameswaran
    Johnson, Bryon
    BLOOD, 2019, 134
  • [6] CD20 and CD19 expression loss in relapsed or refractory b-cell non-Hodgkin lymphoma: A retrospective cohort.
    Marshalek, Joseph Patrick
    Dragan, Marcin
    Tomassetti, Sarah
    LaBarbera, Katie
    Amaya, Andy
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Killing of non-Hodgkin lymphoma cells by autologous CD19 engineered T cells
    Cheadle, EJ
    Gilham, DE
    Thistlethwaite, FC
    Radford, JA
    Hawkins, RE
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (03) : 322 - 332
  • [8] Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial
    Wang, Lixin
    Fang, Chuling
    Kang, Qingzheng
    Huang, Wenfa
    Chen, Ziren
    Zhao, Weiqiang
    Wang, Lei
    Wang, Yiran
    Tan, Kun
    Guo, Xiao
    Xu, Yuanyuan
    Wang, Shuhong
    Wang, Lijun
    Qiao, Jingqiao
    Tang, Zhixiong
    Yu, Chuan
    Xu, Yang
    Li, Yisheng
    Yu, Li
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [9] Cellular Kinetics of CD19 Chimeric Antigen Receptor T Cells in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma
    Li, Caixia
    Zhang, Changfeng
    Zhang, Ying
    Lou, Xiaoyan
    Zhang, Jinfang
    Chen, Jia
    Chen, Xiaochen
    Kang, Liqing
    Zhou, Jin
    Zong, Xiangping
    Yang, Zhen
    Li, Jiaqi
    Qi, Wei
    Yu, Lei
    Wu, Depei
    BLOOD, 2019, 134
  • [10] A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
    Zhang, Ying
    Li, Jiaqi
    Lou, Xiaoyan
    Chen, Xiaochen
    Yu, Zhou
    Kang, Liqing
    Chen, Jia
    Zhou, Jin
    Zong, Xiangping
    Yang, Zhen
    Li, Minghao
    Xu, Nan
    Jia, Sixun
    Geng, Hongzhi
    Chen, Guanghua
    Dai, Haiping
    Tang, Xiaowen
    Yu, Lei
    Wu, Depei
    Li, Caixia
    FRONTIERS IN ONCOLOGY, 2021, 11
12345